Table 2.
Comparison of adverse effects between the study groups
| Treatment group | Frequency of adverse effects | |
|---|---|---|
| Erythema | Irritation | |
| TA | Nil | 3 (6%) |
| HQ | 10 (20%) | 09 (18%) |
| P-value < 0.05 | ||
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.